Filter Results
Products (94)

"���������������katalk:PC53������������ ��� ������ ������������������������,������������������,������������������,������������������" has 94 results in Products.

Results per Page:

PKI 14-22 amide, myristoylated

Cat. No. 2546/1
Description: Cell-permeable protein kinase A inhibitor
Pricing & Availability Qty

Sotalol hydrochloride

Cat. No. 0952/10
Description: β antagonist
Purity: ≥99% (HPLC)
Pricing & Availability Qty

Piceatannol

Cat. No. 1554/10
Description: Inhibits TNF-induced NF-κB activation
Purity: ≥98% (HPLC)
Pricing & Availability Qty

Hemopressin (rat)

Cat. No. 1764/1
Description: Selective CB1 inverse agonist
Pricing & Availability Qty

PSB 36

Cat. No. 2019/10
Description: Potent and selective A1 antagonist
Purity: ≥99% (HPLC)
Pricing & Availability Qty

Lenalidomide 4'-alkylC5-azide

Cat. No. 7517/25
Description: Cereblon ligand with alkyl linker and terminal azide for onward chemistry
Purity: ≥95% (HPLC)
Pricing & Availability Qty

Pomalidomide 4'-alkylC6-azide

Cat. No. 7443/25
Description: Cereblon ligand with alkyl linker and terminal azide for onward chemistry
Purity: ≥95% (HPLC)
Pricing & Availability Qty

Pomalidomide 4'-alkylC5-azide

Cat. No. 7442/25
Description: Cereblon ligand with alkyl linker and terminal azide for onward chemistry
Purity: ≥95% (HPLC)
Pricing & Availability Qty

Pomalidomide 4'-alkylC4-azide

Cat. No. 7441/25
Description: Cereblon ligand with alkyl linker and terminal azide for onward chemistry
Purity: ≥95% (HPLC)
Pricing & Availability Qty

Pomalidomide 4'-alkylC3-azide

Cat. No. 7440/25
Description: Cereblon ligand with alkyl linker and terminal azide for onward chemistry
Purity: ≥95% (HPLC)
Pricing & Availability Qty
Pageof 10

"���������������katalk:PC53������������ ��� ������ ������������������������,������������������,������������������,������������������" has results in Targets.

"���������������katalk:PC53������������ ��� ������ ������������������������,������������������,������������������,������������������" has results in Resources.